deltatrials

Gastroesophageal reflux disease Trials in Kansas City, United States

Conditions / Gastroesophageal reflux disease / Kansas City, United States

Gastroesophageal reflux disease is a medical condition with active clinical research programs worldwide.

10 total trials for this combination

Trials

NCT ID Title Status Phase
NCT01572974 Quality of Life in Barrett's Esophagus and Gastro-Esophageal Reflux Disease TERMINATED
NCT00885469 PillCam® ESO 2 in Esophageal Pathologies COMPLETED
NCT02186652 PK Study With Pantoprazole in Obese Children and Adolescents COMPLETED PHASE1
NCT00251758 Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn COMPLETED PHASE3
NCT00287612 Necessity of Esophageal Dissection During Laparoscopic Fundoplication COMPLETED NA
NCT01642602 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents COMPLETED PHASE2
NCT01580631 Narrow Band Imaging Project on Barrett's Esophagus SUSPENDED
NCT00255190 Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn COMPLETED PHASE3
NCT00574327 Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the Creation of a Barrett's Registry RECRUITING
NCT01642615 Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents COMPLETED PHASE2

Related Pages